Bavarian Nordic reports positive data from Phase II Covid-19 booster trial
In the trial, vaccination with ABNCoV2 led to a substantial improvement in neutralising antibodies against the Omicron variant.
Denmark
Latest in
Denmark
Leo Pharma partners with Veeva Systems to digitalise clinical trials
LEO Pharma will use Veeva’s CDMS, eConsent, eTMF, CTMS, Site Connect, ePRO, Virtual Visits, and eSource products.
Bavarian Nordic starts Phase II Covid-19 booster vaccine study
The trial will enrol a total of up to 210 healthy adults in Germany who will receive a single or…
Bavarian Nordic’s Covid-19 vaccine yields positive Phase I/II data
The vaccine showed favourable tolerability and safety profile, as well as generated high antibody titres against SARS-CoV-2.
Novo Nordisk reports positive data from type 2 diabetes medicine trial
Novo Nordisk has announced positive headline results from Phase IIIb SUSTAIN FORTE trial of once-weekly semaglutide 1mg versus 2mg dose…
Novo Nordisk to restart Phase III haemophilia trials of concizumab
Novo Nordisk is set to resume the Phase III explorer 6, 7 and 8 clinical trials of concizumab as a…
Orphazyme finds reduced Niemann-Pick disease progression in trial
Biopharmaceutical firm Orphazyme has reported positive interim results from an open-label extension study of a Phase II/III clinical trial of…
Bavarian Nordic reports Phase III data for smallpox vaccine
Bavarian Nordic has reported data from the Phase III efficacy study of MVA-BN (Jynneos) vaccine, which is designed to prevent…